DK1007097T3 - Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler - Google Patents

Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler

Info

Publication number
DK1007097T3
DK1007097T3 DK98906986T DK98906986T DK1007097T3 DK 1007097 T3 DK1007097 T3 DK 1007097T3 DK 98906986 T DK98906986 T DK 98906986T DK 98906986 T DK98906986 T DK 98906986T DK 1007097 T3 DK1007097 T3 DK 1007097T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
formulation
acid particles
transfection agents
cationic transfection
Prior art date
Application number
DK98906986T
Other languages
Danish (da)
English (en)
Inventor
Bruno Pitard
Joel Crouzet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1007097(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1007097T3 publication Critical patent/DK1007097T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK98906986T 1997-02-10 1998-02-06 Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler DK1007097T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (1)

Publication Number Publication Date
DK1007097T3 true DK1007097T3 (da) 2002-02-11

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98906986T DK1007097T3 (da) 1997-02-10 1998-02-06 Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler

Country Status (20)

Country Link
EP (1) EP1007097B1 (es)
JP (1) JP2001511171A (es)
KR (1) KR20000070914A (es)
AT (1) ATE206932T1 (es)
AU (1) AU737720B2 (es)
BR (1) BR9807563A (es)
CA (1) CA2278665A1 (es)
CZ (1) CZ282199A3 (es)
DE (1) DE69802102T2 (es)
DK (1) DK1007097T3 (es)
ES (1) ES2166146T3 (es)
FR (1) FR2759298B1 (es)
GR (1) GR3036919T3 (es)
HU (1) HUP0001720A3 (es)
IL (1) IL130765A0 (es)
NO (1) NO993825D0 (es)
PT (1) PT1007097E (es)
SK (1) SK282685B6 (es)
WO (1) WO1998034648A1 (es)
ZA (1) ZA981034B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
US6583301B1 (en) * 1998-04-08 2003-06-24 Celltech R & D Limited Lipids
JP2002520038A (ja) * 1998-07-20 2002-07-09 アイネックス ファーマシューティカルズ コーポレイション リポソームカプセル化核酸複合体
EP1309904A4 (en) * 2000-03-03 2006-03-29 Valentis Inc IMPROVED POLOXAMER AND POLYOAMINE COMPOUNDS FOR NUCLEINE SUCTION INTRODUCTION
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
DE60144338D1 (de) * 2000-10-20 2011-05-12 Vical Inc Gen-abgabeformulierungen zur behandlung ischämischer zustände
EP1232758A1 (fr) * 2001-02-19 2002-08-21 Aventis Pasteur Polynucléotide formulé en vue d'un transfert intracellulaire amélioré
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
KR101284710B1 (ko) * 2004-03-03 2013-07-23 레반스 테라퓨틱스, 아이엔씨. 국소 진단제 및 치료제의 수송을 위한 조성물 및 방법
BRPI0608249A2 (pt) 2005-03-03 2009-12-08 Revance Therapeutics Inc formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
WO1996030051A1 (en) * 1995-03-31 1996-10-03 Genetic Therapy, Inc. Use of surfactants for introducing genetic material into lung cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
AU6298798A (en) 1998-08-26
NO993825L (no) 1999-08-09
FR2759298B1 (fr) 1999-04-09
SK108299A3 (en) 2000-05-16
AU737720B2 (en) 2001-08-30
HUP0001720A1 (hu) 2000-09-28
EP1007097A1 (fr) 2000-06-14
EP1007097B1 (fr) 2001-10-17
CA2278665A1 (fr) 1998-08-13
BR9807563A (pt) 2000-02-01
HUP0001720A3 (en) 2001-10-29
NO993825D0 (no) 1999-08-09
FR2759298A1 (fr) 1998-08-14
DE69802102T2 (de) 2002-03-14
JP2001511171A (ja) 2001-08-07
CZ282199A3 (cs) 1999-10-13
KR20000070914A (ko) 2000-11-25
ES2166146T3 (es) 2002-04-01
PT1007097E (pt) 2002-04-29
SK282685B6 (sk) 2002-11-06
WO1998034648A1 (fr) 1998-08-13
ATE206932T1 (de) 2001-11-15
IL130765A0 (en) 2001-01-28
GR3036919T3 (en) 2002-01-31
ZA981034B (en) 1998-08-11
DE69802102D1 (de) 2001-11-22

Similar Documents

Publication Publication Date Title
DK1007097T3 (da) Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
EP0911039A3 (en) Drug-resin complexes stabilized by chelating agents
FR2791895B1 (fr) Utilisation de trehalose pour stabiliser un vaccin liquide
PT1123120E (pt) Formulacao medicinal em aerossol
TR199500299A2 (tr) Farmasötik bilesimler.
PT1047406E (pt) Composicoes farmaceuticas autoclavaveis contendo um agente quelante
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
MX9804848A (es) Emulsiones estables que comprenden un ingrediente liquido hidrofobico.
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
DE69807065D1 (de) Topische mittel
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
MXPA04001007A (es) Emulsion inversa que contiene dihidroepiandrosterona.
ATE174955T1 (de) Stabile, nichtionische tensidemulsionen, welche viskositätskontrollmittel enthalten
ES2179508T3 (es) Composicion cosmetica que comprende una amida y nuevas amidas.
EP1003606A4 (en) SURFACTANT MIXTURES CONTAINING ALKYLPOLYGLYCOSIDES FOR EMULSION POLYMERIZATION
TR199801460T2 (xx) Renk stabilize edici(ler) ve s�rfaktan(lar)� i�eren temizleyici bile�im.
DE69429252T2 (de) Fluessige arzneizusammensetzungen enthaltend ibuprofen
EP1385948A4 (en) NUCLEIC ACIDS FOR INHIBITING THE EXPRESSION OF HAIRLESS PROTEIN AND METHOD FOR USE THEREOF
HUP0202378A3 (en) Surfactant mixture, emulsion containing thereof structured surfactant composition and detergent composition
ATE310075T1 (de) Reinigungsmittelkomponente mit feinteiligen feststoffen
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
Kamioka Dynamics and kinetics of oxidation of semiconductor surfaces